Aetna expands bundled oncology prior authorizations, easing provider burden and accelerating member access to care

Aetna broadens its cancer treatment prior authorization bundles for Medicaid members now and targets all business lines, including Medicare and Commercial, by 2027.

Rhea-AI Summary

Aetna (CVS) is expanding bundled oncology prior authorizations to cover all cancer types for eligible Medicaid members as of September 1, with a full roll-out across all Aetna lines of business planned for 2027.

The bundles consolidate medical oncology, radiation oncology and related high-tech imaging, such as MRI or CT scans, into a single prior authorization submitted via one portal, replacing an average of four separate requests per cancer patient. Nearly 25% of eligible members have already received a bundled prior authorization, which pre-approves services to help accelerate access to care and reduce paperwork for providers.

Survey data from Aetna show that 74% of providers view administrative burden as the top challenge for clinical staff, and 31% cite prior authorization management as the largest contributor. The company expects to extend bundle eligibility to Medicare and Commercial members in the first half of 2027.

Market Context

At publication, CVS was down 2.93% pre-headline while all five listed healthcare-plan peers were als...

Analysis

At publication, CVS was down 2.93% pre-headline while all five listed healthcare-plan peers were also lower, placing Aetna’s authorization-bundle expansion in a broader negative sector tape; no peer headline tied the move to this announcement.

Key Figures

Medicaid rollout: September 1 Eligible member utilization: almost 25% Prior authorizations per member: 4 +5 more

Medicaid rollout

September 1

Bundled prior authorizations for eligible Medicaid members

Eligible member utilization

almost 25%

Eligible members receiving a bundled prior authorization

Prior authorizations per member

4

Average separate authorizations submitted for cancer treatments

Administrative burden

74%

Providers identifying it as the top challenge facing clinical staff

Prior authorization contribution

31%

Providers citing prior authorization management as the largest contributor

Potential daily time savings

more than an hour

30% of survey respondents believed technology solutions could save this amount

Expected daily time savings

more than 30 minutes

80% of survey respondents expected this savings from technology solutions

Medicare and Commercial expansion

first half of 2027

Expected eligibility expansion

Key Terms

prior authorization, immunotherapy, medical oncology, radiation oncology

4 terms

prior authorization regulatory

"Aetna is expanding prior authorization bundles across all cancer types"

Prior authorization is a process where a health insurance company requires approval before covering certain medical services or medications. It functions like a pre-approval step, ensuring that the treatment is necessary and appropriate before expenses are paid. For investors, understanding prior authorization is important because delays or denials can impact healthcare costs, provider operations, and the financial stability of related companies.

immunotherapy medical

"including chemotherapy and immunotherapy where appropriate"

Treatment that uses or enhances the body’s immune system to detect and fight disease, most often cancers or chronic infections; think of it as training or arming the body’s own soldiers to find and destroy targets. It matters to investors because successful immunotherapies can lead to high-value drug approvals, recurring revenue from long-term treatments, and changes in competitive dynamics, while failures or safety issues in clinical trials can materially affect company valuations.

medical oncology medical

"Prior authorization bundles combine medical oncology"

Medical oncology is the branch of medicine focused on diagnosing and treating cancer using drug-based therapies such as chemotherapy, targeted treatments and immunotherapies, along with coordinating patient care through treatment plans and follow-up. It matters to investors because advances, trial results, regulatory approvals or safety concerns in this field directly affect drug developers’ revenue potential, partnership value and market forecasts—think of it as the strategy and playbook that determines whether a cancer drug succeeds or fails commercially.

radiation oncology medical

"and/or radiation oncology services with associated high-tech imaging needs"

Radiation oncology is the medical specialty that uses carefully controlled beams of radiation to shrink or destroy tumors, much like using a focused heat lamp or precise scissors to remove a problem area without cutting away healthy tissue. For investors, it matters because demand for radiation oncology drives sales of expensive machines, software, treatment services and related drugs, and is influenced by regulation, reimbursement and technological advances that can change profit potential across equipment makers, hospitals and service providers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Oncology bundling to support all eligible Medicaid members for all cancer types
• Full roll-out across all Aetna businesses in 2027

HARTFORD, Conn., Sept. 17, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS), is expanding prior authorization bundles across all cancer types for members in eligible¹ Medicaid states as of September 1, with plans to expand across all lines of business in 2027. This expansion builds on the success of the initial roll-out, with almost 25% of eligible members receiving a bundled prior authorization, assuring their services have been approved in advance to accelerate their access to care.

On average, Aetna saw that providers were submitting four separate prior authorizations for each member in need of cancer treatments². By offering a single, secure prior authorization for a bundle of cancer treatments, Aetna is helping patients access care simply throughout their treatment journey. Prior authorization bundles combine medical oncology, including chemotherapy and immunotherapy where appropriate, and/or radiation oncology services with associated high-tech imaging needs, such as MRI or CT scans, into one request submitted through a single portal.

"A cancer diagnosis can be overwhelming for patients and families, and the care team should be focused on their patient, not paperwork," said Katerina Guerraz, Aetna Chief Operating Officer and President of Medicaid. "By approving a broader set of treatments and related services upfront, we're removing barriers that can delay care. Oncologists have the flexibility to make care decisions as treatment plans evolve, and individuals can focus on what matters most: their health, recovery, and time with their loved ones."

Administrative burden remains a significant challenge for healthcare providers. According to the latest Aetna Provider Survey, 74% of providers identified administrative burden as the top challenge facing clinical staff today, and nearly one-third (31%) cited prior authorization management as the single largest contributor.

By reducing this burden, Aetna can help clinicians unlock more time for patient care. In fact, 30% of Aetna Provider Survey respondents believed they could save more than an hour and 80% expect to save more than 30 minutes daily on administrative tasks through technology solutions such as bundles. 

Aetna expects to expand eligibility to Medicare and Commercial members in the first half of 2027.

1. Providers in OK, IL, MD, NJ, VA, FL, KY, WV that utilize the Eviti portal to submit prior authorizations.
2. Aetna Data Sciences

About Aetna
Aetna, a CVS Health business, serves an estimated 37 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care professionals, governmental units, government-sponsored plans, labor groups and expatriates. For more information, visit Aetna.com (e.g., clinical diagnoses, eligibility criteria, participation in a disease state management program).

About CVS Health
CVS Health is a leading health solutions company simplifying health care one person, one family and one community at a time. As of June 30, 2026, the Company had approximately 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics and a leading pharmacy benefits manager with approximately 87 million plan members. The Company also serves an estimated 37 million people through a broad range of health insurance products and related services. The Company's integrated model uses personalized, technology driven services to connect people to simply better health, increasing access to quality care, delivering better outcomes, and lowering overall costs.

Media contact
Phil Blando
Phillip.blando@cvshealth.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/aetna-expands-bundled-oncology-prior-authorizations-easing-provider-burden-and-accelerating-member-access-to-care-302880952.html

SOURCE CVS Health

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What services are included in Aetna's oncology prior authorization bundles?

The bundles combine medical oncology treatments, including chemotherapy and immunotherapy where appropriate, and/or radiation oncology services with associated high-tech imaging such as MRI or CT scans, into a single prior authorization request through one portal.

How does the bundled prior authorization change provider workflows?

Providers previously submitted an average of four separate prior authorizations per member needing cancer treatment. With the bundle, they submit one secure request that covers a broader set of treatments and related services, which the company says is intended to reduce administrative burden and free up more time for patient care.

What do Aetna's provider survey results indicate about administrative burden?

In the latest Aetna Provider Survey, 74% of providers identified administrative burden as the top challenge facing clinical staff, and 31% cited prior authorization management as the single largest contributor. Among respondents, 30% believed they could save more than an hour daily and 80% expected to save more than 30 minutes per day on administrative tasks through technology solutions such as bundles.

When will Medicare and Commercial members become eligible for oncology bundles?

Aetna expects to expand oncology prior authorization bundle eligibility to Medicare and Commercial members in the first half of 2027 as part of the broader roll-out across all lines of business.

Which providers currently use the Eviti portal for submitting oncology prior authorizations?

Providers in Oklahoma, Illinois, Maryland, New Jersey, Virginia, Florida, Kentucky, and West Virginia that utilize the Eviti portal submit prior authorizations through that platform.